Global Eukaryotic Expression Systems Market Size, Status and Forecast 2021-2027

真核生物発現システムの世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Eukaryotic Expression Systems Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR2260
◆調査・発行会社:QYResearch
◆発行日:2021年4月
◆ページ数:98
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、主要地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥444,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥666,900見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥889,200見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、真核生物発現システムの世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(試薬、発現ベクター、コンピテントセル)、用途別市場規模(細菌発現システム、酵母発現システム、昆虫発現システム、哺乳類発現システム)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・真核生物発現システムの市場動向
・企業の競争状況、市場シェア
・真核生物発現システムの種類別市場規模(試薬、発現ベクター、コンピテントセル)
・真核生物発現システムの用途別市場規模(細菌発現システム、酵母発現システム、昆虫発現システム、哺乳類発現システム)
・真核生物発現システムの北米市場規模2016-2027(アメリカ、カナダ)
・真核生物発現システムの欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・真核生物発現システムのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・真核生物発現システムの中南米市場規模2016-2027(メキシコ、ブラジル)
・真核生物発現システムの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Thermo Fisher、Sigma Aldrich、Jena Bioscience、New England Biolabs、Takara Bio、Bio Rad、Promega、Agilent、Merck Millipore)
・結論

Market Analysis and Insights: Global Eukaryotic Expression Systems Market
The global Eukaryotic Expression Systems market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Eukaryotic Expression Systems market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Eukaryotic Expression Systems market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Eukaryotic Expression Systems market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Eukaryotic Expression Systems market.

Global Eukaryotic Expression Systems Scope and Market Size
Eukaryotic Expression Systems market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Eukaryotic Expression Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Reagents
Expression vectors
Competent cells

Segment by Application
Bacterial Expression System
Yeast Expression System
Insect Expression System
Mammalian Expression System

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Thermo Fisher
Sigma Aldrich
Jena Bioscience
New England Biolabs
Takara Bio
Bio Rad
Promega
Agilent
Merck Millipore

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Eukaryotic Expression Systems Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Reagents
1.2.3 Expression vectors
1.2.4 Competent cells
1.3 Market by Application
1.3.1 Global Eukaryotic Expression Systems Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Bacterial Expression System
1.3.3 Yeast Expression System
1.3.4 Insect Expression System
1.3.5 Mammalian Expression System
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Eukaryotic Expression Systems Market Perspective (2016-2027)
2.2 Eukaryotic Expression Systems Growth Trends by Regions
2.2.1 Eukaryotic Expression Systems Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Eukaryotic Expression Systems Historic Market Share by Regions (2016-2021)
2.2.3 Eukaryotic Expression Systems Forecasted Market Size by Regions (2022-2027)
2.3 Eukaryotic Expression Systems Industry Dynamic
2.3.1 Eukaryotic Expression Systems Market Trends
2.3.2 Eukaryotic Expression Systems Market Drivers
2.3.3 Eukaryotic Expression Systems Market Challenges
2.3.4 Eukaryotic Expression Systems Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Eukaryotic Expression Systems Players by Revenue
3.1.1 Global Top Eukaryotic Expression Systems Players by Revenue (2016-2021)
3.1.2 Global Eukaryotic Expression Systems Revenue Market Share by Players (2016-2021)
3.2 Global Eukaryotic Expression Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Eukaryotic Expression Systems Revenue
3.4 Global Eukaryotic Expression Systems Market Concentration Ratio
3.4.1 Global Eukaryotic Expression Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Eukaryotic Expression Systems Revenue in 2020
3.5 Eukaryotic Expression Systems Key Players Head office and Area Served
3.6 Key Players Eukaryotic Expression Systems Product Solution and Service
3.7 Date of Enter into Eukaryotic Expression Systems Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Eukaryotic Expression Systems Breakdown Data by Type
4.1 Global Eukaryotic Expression Systems Historic Market Size by Type (2016-2021)
4.2 Global Eukaryotic Expression Systems Forecasted Market Size by Type (2022-2027)

5 Eukaryotic Expression Systems Breakdown Data by Application
5.1 Global Eukaryotic Expression Systems Historic Market Size by Application (2016-2021)
5.2 Global Eukaryotic Expression Systems Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Eukaryotic Expression Systems Market Size (2016-2027)
6.2 North America Eukaryotic Expression Systems Market Size by Type
6.2.1 North America Eukaryotic Expression Systems Market Size by Type (2016-2021)
6.2.2 North America Eukaryotic Expression Systems Market Size by Type (2022-2027)
6.2.3 North America Eukaryotic Expression Systems Market Size by Type (2016-2027)
6.3 North America Eukaryotic Expression Systems Market Size by Application
6.3.1 North America Eukaryotic Expression Systems Market Size by Application (2016-2021)
6.3.2 North America Eukaryotic Expression Systems Market Size by Application (2022-2027)
6.3.3 North America Eukaryotic Expression Systems Market Size by Application (2016-2027)
6.4 North America Eukaryotic Expression Systems Market Size by Country
6.4.1 North America Eukaryotic Expression Systems Market Size by Country (2016-2021)
6.4.2 North America Eukaryotic Expression Systems Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Eukaryotic Expression Systems Market Size (2016-2027)
7.2 Europe Eukaryotic Expression Systems Market Size by Type
7.2.1 Europe Eukaryotic Expression Systems Market Size by Type (2016-2021)
7.2.2 Europe Eukaryotic Expression Systems Market Size by Type (2022-2027)
7.2.3 Europe Eukaryotic Expression Systems Market Size by Type (2016-2027)
7.3 Europe Eukaryotic Expression Systems Market Size by Application
7.3.1 Europe Eukaryotic Expression Systems Market Size by Application (2016-2021)
7.3.2 Europe Eukaryotic Expression Systems Market Size by Application (2022-2027)
7.3.3 Europe Eukaryotic Expression Systems Market Size by Application (2016-2027)
7.4 Europe Eukaryotic Expression Systems Market Size by Country
7.4.1 Europe Eukaryotic Expression Systems Market Size by Country (2016-2021)
7.4.2 Europe Eukaryotic Expression Systems Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Eukaryotic Expression Systems Market Size (2016-2027)
8.2 Asia-Pacific Eukaryotic Expression Systems Market Size by Type
8.2.1 Asia-Pacific Eukaryotic Expression Systems Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Eukaryotic Expression Systems Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Eukaryotic Expression Systems Market Size by Type (2016-2027)
8.3 Asia-Pacific Eukaryotic Expression Systems Market Size by Application
8.3.1 Asia-Pacific Eukaryotic Expression Systems Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Eukaryotic Expression Systems Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Eukaryotic Expression Systems Market Size by Application (2016-2027)
8.4 Asia-Pacific Eukaryotic Expression Systems Market Size by Region
8.4.1 Asia-Pacific Eukaryotic Expression Systems Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Eukaryotic Expression Systems Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Eukaryotic Expression Systems Market Size (2016-2027)
9.2 Latin America Eukaryotic Expression Systems Market Size by Type
9.2.1 Latin America Eukaryotic Expression Systems Market Size by Type (2016-2021)
9.2.2 Latin America Eukaryotic Expression Systems Market Size by Type (2022-2027)
9.2.3 Latin America Eukaryotic Expression Systems Market Size by Type (2016-2027)
9.3 Latin America Eukaryotic Expression Systems Market Size by Application
9.3.1 Latin America Eukaryotic Expression Systems Market Size by Application (2016-2021)
9.3.2 Latin America Eukaryotic Expression Systems Market Size by Application (2022-2027)
9.3.3 Latin America Eukaryotic Expression Systems Market Size by Application (2016-2027)
9.4 Latin America Eukaryotic Expression Systems Market Size by Country
9.4.1 Latin America Eukaryotic Expression Systems Market Size by Country (2016-2021)
9.4.2 Latin America Eukaryotic Expression Systems Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Eukaryotic Expression Systems Market Size (2016-2027)
10.2 Middle East & Africa Eukaryotic Expression Systems Market Size by Type
10.2.1 Middle East & Africa Eukaryotic Expression Systems Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Eukaryotic Expression Systems Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Eukaryotic Expression Systems Market Size by Type (2016-2027)
10.3 Middle East & Africa Eukaryotic Expression Systems Market Size by Application
10.3.1 Middle East & Africa Eukaryotic Expression Systems Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Eukaryotic Expression Systems Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Eukaryotic Expression Systems Market Size by Application (2016-2027)
10.4 Middle East & Africa Eukaryotic Expression Systems Market Size by Country
10.4.1 Middle East & Africa Eukaryotic Expression Systems Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Eukaryotic Expression Systems Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Details
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Eukaryotic Expression Systems Introduction
11.1.4 Thermo Fisher Revenue in Eukaryotic Expression Systems Business (2016-2021)
11.1.5 Thermo Fisher Recent Development
11.2 Sigma Aldrich
11.2.1 Sigma Aldrich Company Details
11.2.2 Sigma Aldrich Business Overview
11.2.3 Sigma Aldrich Eukaryotic Expression Systems Introduction
11.2.4 Sigma Aldrich Revenue in Eukaryotic Expression Systems Business (2016-2021)
11.2.5 Sigma Aldrich Recent Development
11.3 Jena Bioscience
11.3.1 Jena Bioscience Company Details
11.3.2 Jena Bioscience Business Overview
11.3.3 Jena Bioscience Eukaryotic Expression Systems Introduction
11.3.4 Jena Bioscience Revenue in Eukaryotic Expression Systems Business (2016-2021)
11.3.5 Jena Bioscience Recent Development
11.4 New England Biolabs
11.4.1 New England Biolabs Company Details
11.4.2 New England Biolabs Business Overview
11.4.3 New England Biolabs Eukaryotic Expression Systems Introduction
11.4.4 New England Biolabs Revenue in Eukaryotic Expression Systems Business (2016-2021)
11.4.5 New England Biolabs Recent Development
11.5 Takara Bio
11.5.1 Takara Bio Company Details
11.5.2 Takara Bio Business Overview
11.5.3 Takara Bio Eukaryotic Expression Systems Introduction
11.5.4 Takara Bio Revenue in Eukaryotic Expression Systems Business (2016-2021)
11.5.5 Takara Bio Recent Development
11.6 Bio Rad
11.6.1 Bio Rad Company Details
11.6.2 Bio Rad Business Overview
11.6.3 Bio Rad Eukaryotic Expression Systems Introduction
11.6.4 Bio Rad Revenue in Eukaryotic Expression Systems Business (2016-2021)
11.6.5 Bio Rad Recent Development
11.7 Promega
11.7.1 Promega Company Details
11.7.2 Promega Business Overview
11.7.3 Promega Eukaryotic Expression Systems Introduction
11.7.4 Promega Revenue in Eukaryotic Expression Systems Business (2016-2021)
11.7.5 Promega Recent Development
11.8 Agilent
11.8.1 Agilent Company Details
11.8.2 Agilent Business Overview
11.8.3 Agilent Eukaryotic Expression Systems Introduction
11.8.4 Agilent Revenue in Eukaryotic Expression Systems Business (2016-2021)
11.8.5 Agilent Recent Development
11.9 Merck Millipore
11.9.1 Merck Millipore Company Details
11.9.2 Merck Millipore Business Overview
11.9.3 Merck Millipore Eukaryotic Expression Systems Introduction
11.9.4 Merck Millipore Revenue in Eukaryotic Expression Systems Business (2016-2021)
11.9.5 Merck Millipore Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Eukaryotic Expression Systems Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Reagents
Table 3. Key Players of Expression vectors
Table 4. Key Players of Competent cells
Table 5. Global Eukaryotic Expression Systems Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Eukaryotic Expression Systems Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Eukaryotic Expression Systems Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Eukaryotic Expression Systems Market Share by Regions (2016-2021)
Table 9. Global Eukaryotic Expression Systems Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Eukaryotic Expression Systems Market Share by Regions (2022-2027)
Table 11. Eukaryotic Expression Systems Market Trends
Table 12. Eukaryotic Expression Systems Market Drivers
Table 13. Eukaryotic Expression Systems Market Challenges
Table 14. Eukaryotic Expression Systems Market Restraints
Table 15. Global Eukaryotic Expression Systems Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Eukaryotic Expression Systems Market Share by Players (2016-2021)
Table 17. Global Top Eukaryotic Expression Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Eukaryotic Expression Systems as of 2020)
Table 18. Ranking of Global Top Eukaryotic Expression Systems Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Eukaryotic Expression Systems Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Eukaryotic Expression Systems Product Solution and Service
Table 22. Date of Enter into Eukaryotic Expression Systems Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Eukaryotic Expression Systems Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Eukaryotic Expression Systems Revenue Market Share by Type (2016-2021)
Table 26. Global Eukaryotic Expression Systems Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Eukaryotic Expression Systems Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Eukaryotic Expression Systems Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Eukaryotic Expression Systems Revenue Market Share by Application (2016-2021)
Table 30. Global Eukaryotic Expression Systems Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Eukaryotic Expression Systems Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Eukaryotic Expression Systems Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Eukaryotic Expression Systems Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Eukaryotic Expression Systems Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Eukaryotic Expression Systems Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Eukaryotic Expression Systems Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Eukaryotic Expression Systems Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Eukaryotic Expression Systems Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Eukaryotic Expression Systems Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Eukaryotic Expression Systems Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Eukaryotic Expression Systems Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Eukaryotic Expression Systems Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Eukaryotic Expression Systems Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Eukaryotic Expression Systems Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Eukaryotic Expression Systems Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Eukaryotic Expression Systems Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Eukaryotic Expression Systems Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Eukaryotic Expression Systems Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Eukaryotic Expression Systems Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Eukaryotic Expression Systems Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Eukaryotic Expression Systems Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Eukaryotic Expression Systems Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Eukaryotic Expression Systems Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Eukaryotic Expression Systems Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Eukaryotic Expression Systems Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Eukaryotic Expression Systems Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Eukaryotic Expression Systems Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Eukaryotic Expression Systems Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Eukaryotic Expression Systems Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Eukaryotic Expression Systems Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Eukaryotic Expression Systems Market Size by Country (2022-2027) & (US$ Million)
Table 62. Thermo Fisher Company Details
Table 63. Thermo Fisher Business Overview
Table 64. Thermo Fisher Eukaryotic Expression Systems Product
Table 65. Thermo Fisher Revenue in Eukaryotic Expression Systems Business (2016-2021) & (US$ Million)
Table 66. Thermo Fisher Recent Development
Table 67. Sigma Aldrich Company Details
Table 68. Sigma Aldrich Business Overview
Table 69. Sigma Aldrich Eukaryotic Expression Systems Product
Table 70. Sigma Aldrich Revenue in Eukaryotic Expression Systems Business (2016-2021) & (US$ Million)
Table 71. Sigma Aldrich Recent Development
Table 72. Jena Bioscience Company Details
Table 73. Jena Bioscience Business Overview
Table 74. Jena Bioscience Eukaryotic Expression Systems Product
Table 75. Jena Bioscience Revenue in Eukaryotic Expression Systems Business (2016-2021) & (US$ Million)
Table 76. Jena Bioscience Recent Development
Table 77. New England Biolabs Company Details
Table 78. New England Biolabs Business Overview
Table 79. New England Biolabs Eukaryotic Expression Systems Product
Table 80. New England Biolabs Revenue in Eukaryotic Expression Systems Business (2016-2021) & (US$ Million)
Table 81. New England Biolabs Recent Development
Table 82. Takara Bio Company Details
Table 83. Takara Bio Business Overview
Table 84. Takara Bio Eukaryotic Expression Systems Product
Table 85. Takara Bio Revenue in Eukaryotic Expression Systems Business (2016-2021) & (US$ Million)
Table 86. Takara Bio Recent Development
Table 87. Bio Rad Company Details
Table 88. Bio Rad Business Overview
Table 89. Bio Rad Eukaryotic Expression Systems Product
Table 90. Bio Rad Revenue in Eukaryotic Expression Systems Business (2016-2021) & (US$ Million)
Table 91. Bio Rad Recent Development
Table 92. Promega Company Details
Table 93. Promega Business Overview
Table 94. Promega Eukaryotic Expression Systems Product
Table 95. Promega Revenue in Eukaryotic Expression Systems Business (2016-2021) & (US$ Million)
Table 96. Promega Recent Development
Table 97. Agilent Company Details
Table 98. Agilent Business Overview
Table 99. Agilent Revenue in Eukaryotic Expression Systems Business (2016-2021) & (US$ Million)
Table 100. Agilent Recent Development
Table 101. Merck Millipore Company Details
Table 102. Merck Millipore Business Overview
Table 103. Merck Millipore Eukaryotic Expression Systems Product
Table 104. Merck Millipore Revenue in Eukaryotic Expression Systems Business (2016-2021) & (US$ Million)
Table 105. Merck Millipore Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Eukaryotic Expression Systems Market Share by Type: 2020 VS 2027
Figure 2. Reagents Features
Figure 3. Expression vectors Features
Figure 4. Competent cells Features
Figure 5. Global Eukaryotic Expression Systems Market Share by Application: 2020 VS 2027
Figure 6. Bacterial Expression System Case Studies
Figure 7. Yeast Expression System Case Studies
Figure 8. Insect Expression System Case Studies
Figure 9. Mammalian Expression System Case Studies
Figure 10. Eukaryotic Expression Systems Report Years Considered
Figure 11. Global Eukaryotic Expression Systems Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Eukaryotic Expression Systems Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Eukaryotic Expression Systems Market Share by Regions: 2020 VS 2027
Figure 14. Global Eukaryotic Expression Systems Market Share by Regions (2022-2027)
Figure 15. Global Eukaryotic Expression Systems Market Share by Players in 2020
Figure 16. Global Top Eukaryotic Expression Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Eukaryotic Expression Systems as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Eukaryotic Expression Systems Revenue in 2020
Figure 18. Global Eukaryotic Expression Systems Revenue Market Share by Type (2016-2021)
Figure 19. Global Eukaryotic Expression Systems Revenue Market Share by Type (2022-2027)
Figure 20. North America Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Eukaryotic Expression Systems Market Share by Type (2016-2027)
Figure 22. North America Eukaryotic Expression Systems Market Share by Application (2016-2027)
Figure 23. North America Eukaryotic Expression Systems Market Share by Country (2016-2027)
Figure 24. United States Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Eukaryotic Expression Systems Market Share by Type (2016-2027)
Figure 28. Europe Eukaryotic Expression Systems Market Share by Application (2016-2027)
Figure 29. Europe Eukaryotic Expression Systems Market Share by Country (2016-2027)
Figure 30. Germany Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Eukaryotic Expression Systems Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Eukaryotic Expression Systems Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Eukaryotic Expression Systems Market Share by Region (2016-2027)
Figure 40. China Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Eukaryotic Expression Systems Market Share by Type (2016-2027)
Figure 48. Latin America Eukaryotic Expression Systems Market Share by Application (2016-2027)
Figure 49. Latin America Eukaryotic Expression Systems Market Share by Country (2016-2027)
Figure 50. Mexico Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Eukaryotic Expression Systems Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Eukaryotic Expression Systems Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Eukaryotic Expression Systems Market Share by Country (2016-2027)
Figure 56. Turkey Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Eukaryotic Expression Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Thermo Fisher Revenue Growth Rate in Eukaryotic Expression Systems Business (2016-2021)
Figure 60. Sigma Aldrich Revenue Growth Rate in Eukaryotic Expression Systems Business (2016-2021)
Figure 61. Jena Bioscience Revenue Growth Rate in Eukaryotic Expression Systems Business (2016-2021)
Figure 62. New England Biolabs Revenue Growth Rate in Eukaryotic Expression Systems Business (2016-2021)
Figure 63. Takara Bio Revenue Growth Rate in Eukaryotic Expression Systems Business (2016-2021)
Figure 64. Bio Rad Revenue Growth Rate in Eukaryotic Expression Systems Business (2016-2021)
Figure 65. Promega Revenue Growth Rate in Eukaryotic Expression Systems Business (2016-2021)
Figure 66. Agilent Revenue Growth Rate in Eukaryotic Expression Systems Business (2016-2021)
Figure 67. Merck Millipore Revenue Growth Rate in Eukaryotic Expression Systems Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[真核生物発現システムの世界市場規模・現状・予測2021年-2027年] (Global Eukaryotic Expression Systems Market Size, Status and Forecast 2021-2027 / QY21APR2260)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆